Fulcrum therapeutics to participate at the cantor fitzgerald global healthcare conference

Cambridge, mass., sept. 22, 2023 (globe newswire) -- fulcrum therapeutics, inc.® (nasdaq: fulc), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that management will participate in a fireside chat at the cantor fitzgerald global healthcare conference, being held in new york, ny on thursday, september 28, 2023 at 8:35 a.m. et.
FULC Ratings Summary
FULC Quant Ranking